DCF — SUMMERSVILLE REGIONAL MED CENTER
Enterprise Value: $-10.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-10.6M
Enterprise Value
$-4.9M
PV of Cash Flows
$-5.6M
PV of Terminal Value
$-9.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $62.5M | $0.5M | 1.0% | $-2.1M | $-1.9M |
| Year 2 | $64.3M | $1.2M | 2.0% | $-1.6M | $-1.3M |
| Year 3 | $66.3M | $1.9M | 3.0% | $-1.0M | $-0.7M |
| Year 4 | $68.3M | $2.3M | 3.0% | $-0.8M | $-0.5M |
| Year 5 | $70.3M | $2.5M | 4.0% | $-0.7M | $-0.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-10.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$60.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0030215280057074166
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5